From promise to practice: Why alternatives to animal testing aren’t yet scalable
As described in last month’s article, New Approach Methodologies (NAMs) and Non-Animal Technologies (NATs), like organoids or fish eggs, are transforming the landscape of biomedical research, toxicology, and drug development. By offering human-relevant insights while reducing or replacing animal use, they hold the promise of more ethical, predictive, and cost-effective science. So, what’s limiting their […]